A Nano-Emulsion Containing Ceramide-like Lipo-Amino Acid Cholesteryl Derivatives Improves Skin Symptoms in Patients with Atopic Dermatitis by Ameliorating the Water-Holding Function

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Nov 11

PMID 36362149

Authors

Mariko Takada

Yuko Ishikawa

Kayoko Numano

Shinichi Hirano

Genji Imokawa

Affiliations

Soon will be listed here.

Abstract

Because ceramide-like lipo-amino acid cholesteryl derivatives can exert a bound water-holding function due to their lamellae-forming properties, in this study, we determined if topical application of those derivatives to atopic dry skin would elicit an ameliorative effect on skin symptoms, at least on its water-holding function. In this clinical study, daily treatment with a nano-emulsion containing 10% phytosteryl/octyldodecyl lauroyl glutamate (POLG) significantly (p < 0.0001) improved skin symptoms, including dryness/scaling, itchiness and stimulus sensations, in the non-lesional skin of patients with atopic dermatitis (AD) at 3 and at 6 weeks compared with week 0. Those significant improvements in skin symptoms were accompanied by a significantly enhanced water content (conductance) and a significant improvement of roughness (SESC) and smoothness (SESM) values measured using a Visioscan at 3 and 6 weeks. Those effects appeared concomitant with a significantly increased corneocyte size, a significantly down-regulated degree of thick abrasions, and a significant impairment of the corneocyte lipid envelope at 6 weeks. Thus, our clinical study suggests, for the first time, that topical application of the POLG nano-emulsion has the distinct potential to ameliorate atopic dry skin symptoms, particularly scaling and itchiness, in the skin of patients with AD. Those effects result from alleviation of the disrupted water-holding function probably due to the increased supply of lamellae structures into the stratum corneum despite the failure to improve barrier function.

Citing Articles

A Chinese drug-compatibility-based approach to purslane hydrogels for acute eczema therapy.

Wang L, Zhang Y, Geng S, Ma L, Wang Y, Han D Front Pharmacol. 2025; 16:1504120.

PMID: 39981178 PMC: 11841398. DOI: 10.3389/fphar.2025.1504120.

Skin Barrier Function and Microtopography in Patients with Atopic Dermatitis.

Pretel-Lara C, Sanabria-de la Torre R, Arias-Santiago S, Montero-Vilchez T J Clin Med. 2024; 13(19).

PMID: 39407921 PMC: 11477937. DOI: 10.3390/jcm13195861.

Explicating the multifunctional roles of tocotrienol and squalene in promoting skin health.

Morgan N, Magalingam K, Radhakrishnan A, Arumugam M, Jamil A, Bhuvanendran S Skin Health Dis. 2024; 4(5):e448.

PMID: 39355739 PMC: 11442061. DOI: 10.1002/ski2.448.

Efficacy of Topical Application of a Skin Moisturizer Containing Pseudo-Ceramide and a Eucalyptus Leaf Extract on Atopic Dermatitis: A Review.

Takagi Y J Clin Med. 2024; 13(6).

PMID: 38541973 PMC: 10970882. DOI: 10.3390/jcm13061749.

Ceramide AD™ Restores Skin Integrity and Function following Exposure to House Dust Mite.

Bzioueche H, Tamelghaghet M, Chignon-Sicard B, Bazile N, Hauchecorne P, Barbero Calderon M Int J Mol Sci. 2023; 24(11).

PMID: 37298186 PMC: 10252232. DOI: 10.3390/ijms24119234.

References

Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A . Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?. J Invest Dermatol. 1991; 96(4):523-6. DOI: 10.1111/1523-1747.ep12470233. View

Imokawa G . Cutting Edge of the Pathogenesis of Atopic Dermatitis: Sphingomyelin Deacylase, the Enzyme Involved in Its Ceramide Deficiency, Plays a Pivotal Role. Int J Mol Sci. 2021; 22(4). PMC: 7916095. DOI: 10.3390/ijms22041613. View

Imokawa G, Yada Y, Higuchi K, Okuda M, Ohashi Y, Kawamata A . Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid-deficient rats and has an inhibitory effect on epidermal hyperplasia. J Clin Invest. 1994; 94(1):89-96. PMC: 296285. DOI: 10.1172/JCI117352. View

Melton J, Wertz P, SWARTZENDRUBER D, Downing D . Effects of essential fatty acid deficiency on epidermal O-acylsphingolipids and transepidermal water loss in young pigs. Biochim Biophys Acta. 1987; 921(2):191-7. DOI: 10.1016/0005-2760(87)90018-x. View

Imokawa G, Akasaki S, Minematsu Y, Kawai M . Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res. 1989; 281(1):45-51. DOI: 10.1007/BF00424272. View

Teranishi Y, Kuwahara H, Ueda M, Takemura T, Kusumoto M, Nakamura K . Sphingomyelin Deacylase, the Enzyme Involved in the Pathogenesis of Atopic Dermatitis, Is Identical to the β-Subunit of Acid Ceramidase. Int J Mol Sci. 2020; 21(22). PMC: 7699893. DOI: 10.3390/ijms21228789. View

Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G . The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J. 2000; 350 Pt 3:747-56. PMC: 1221306. View

RAJKA G, Langeland T . Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1989; 144:13-4. DOI: 10.2340/000155551441314. View

Kawai M, Imokawa G, Mizoguchi M . [Physiological analysis of the facial skin by corneocyte morphology and stratum corneum turnover]. Nihon Hifuka Gakkai Zasshi. 1989; 99(9):999-1006. View

10.

de Melo M, Maia Campos P . Characterization of oily mature skin by biophysical and skin imaging techniques. Skin Res Technol. 2018; 24(3):386-395. DOI: 10.1111/srt.12441. View

11.

Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M . Analysis of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol. 1994; 74(5):337-40. DOI: 10.2340/0001555574337340. View

12.

Leung D . Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol. 2000; 105(5):860-76. DOI: 10.1067/mai.2000.106484. View

13.

Imokawa G . A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J Dermatol Sci. 2009; 55(1):1-9. DOI: 10.1016/j.jdermsci.2009.04.006. View

14.

Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Higuchi K . Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency?. J Invest Dermatol. 1996; 106(6):1242-9. DOI: 10.1111/1523-1747.ep12348937. View

15.

Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G . Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol. 2002; 119(2):433-9. DOI: 10.1046/j.1523-1747.2002.01846.x. View

16.

Ishibashi M, Arikawa J, Okamoto R, Kawashima M, Takagi Y, Ohguchi K . Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. Lab Invest. 2003; 83(3):397-408. DOI: 10.1097/01.lab.0000059931.66821.92. View

17.

Hata M, Tokura Y, Takigawa M, Sato M, Shioya Y, Fujikura Y . Assessment of epidermal barrier function by photoacoustic spectrometry in relation to its importance in the pathogenesis of atopic dermatitis. Lab Invest. 2002; 82(11):1451-61. DOI: 10.1097/01.lab.0000036874.83540.2b. View

18.

Ishida K, Takahashi A, Bito K, Draelos Z, Imokawa G . Treatment with Synthetic Pseudoceramide Improves Atopic Skin, Switching the Ceramide Profile to a Healthy Skin Phenotype. J Invest Dermatol. 2020; 140(9):1762-1770.e8. DOI: 10.1016/j.jid.2020.01.014. View

19.

Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G . High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol. 2000; 115(3):406-13. DOI: 10.1046/j.1523-1747.2000.00072.x. View

20.

Okamoto R, Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Imokawa G . Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. J Lipid Res. 2003; 44(1):93-102. DOI: 10.1194/jlr.m200225-jlr200. View